Aton Pharma products
Carbidopa
Indication: Adjunctive therapy for nausea (commonly with medications like levodopa to reduce peripheral side effects).
Status: Approved and marketed.
Pyroxamide (HDAC inhibitor)
Indication: Investigational use in neoplasms (cancer treatment).
Status: Pipeline candidate (pending development).
No comments:
Post a Comment